-
Infographic – Biomedical Innovation Gains Continue
Two statistical indicators provide more evidence that innovations in health and medicine are continuing their sharp upward climb.
-
Portable Testing Device IDs Covid-19 Variants
A low-cost device is being developed that analyzes saliva samples for SARS-CoV-2 viral mutations, and returns results in about one hour.
-
Protein Chemistry Biotech Acquired in $2B Deal
Drug maker Bayer is acquiring a company discovering new therapies with a technology that reveals complex protein targets considered difficult to address.
-
Tech Shaping the Post-Covid Healthcare Landscape
Tech adopted during the pandemic looks set to continue as we transition into a world where the virus doesn’t control us.
-
NIH Funds Programmable mRNA to Treat Cancer
National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of solid tumor cancer.
-
Sanofi Acquires mRNA Developer in $3.2B Deal
Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator.
-
Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal
A French biopharmaceutical company is gaining access to a technology using synthetic nucleic acids to treat rare genetic neurological diseases.
-
Infographic – Majorities Favor U.S. Vaccine Mandates
As the more contagious delta variant becomes the dominant SARS-CoV-2 strain, a clear majority of American adults now favors employers mandating Covid-19 vaccines.
-
Going Freelance: What Engineers Need To Know
Becoming a full-time freelancer is an incredibly exciting time as you can finally take full responsibility for your work.
-
Pharma, Biotech Partner on Off-the-Shelf Cell Therapies
A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells.